Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts

Journal of Child and Adolescent Psychopharmacology

Volumn 18, Issue 5, 2008, Pages 509-515

  Budman, Cathy ^a   Coffey, Barbara J ^b   Shechter, Rachel ^b   Schrock, Matthew ^b   Wieland, Natalie ^b   Spirgel, Arie ^b   Simon, Elizabeth ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b NEW YORK UNIVERSITY CHILD STUDY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; PSYCHOTROPIC AGENT;

ADULT; AGITATION; AKATHISIA; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; BRADYKINESIA; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL GLOBAL IMPRESSION SCALE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GILLES DE LA TOURETTE SYNDROME; HEADACHE; HUMAN; INTERMITTENT EXPLOSIVE DISORDER; MALE; MENTAL INSTABILITY; NAUSEA; OBSESSIVE COMPULSIVE DISORDER; PARKINSONISM; SCHOOL CHILD; SEDATION; SIDE EFFECT; TIC; TREATMENT RESPONSE; TREMOR; WEIGHT GAIN; WEIGHT REDUCTION;

ADOLESCENT; AGGRESSION; ANTIPSYCHOTIC AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD BEHAVIOR DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; PIPERAZINES; PSYCHIATRIC STATUS RATING SCALES; QUINOLONES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TOURETTE SYNDROME; TREATMENT OUTCOME;

EID: 54249089359     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2007.061     Document Type: Article

References (53)

1. Alessi N, Radwan K: Aripiprazole and atypical neuroleptic malignant syndrome. J Am Acad Child Adolesc Psychiatry 43:1457-1458, 2004.
2. Albin RL: Neurobiology of Basal Ganglia and TS. Cleveland, Ohio, International Tourette Syndrome Association Scientific Meeting, 2004 (abstract).
3. Aman MG, De Smedt G, Derivan A, Lyons B, Findling RL: Double-blind placebo controlled study of risperidone in the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry 159:1337-1346, 2002.
4. th ed. text revision (DSM-IVTR). Washington, DC: American Psychiatric Association, 2000.
5. Benedetti F, Sforzini L, Colombo C, Maffei C, Smearaldi E: Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder. J Clin Psychiatry 59:103-107, 1998.
6. Bruun RD, Budman CL: Paroxetine as a treatment for anger attacks in patients with Tourette syndrome. J Clin Psychiatry 59:581-588, 1998.
7. Budman CL, Feirman L: The relationship of Tourette syndrome with its psychiatric comorbidities: Is there an overlap? Psychiatr Ann 31:541-548, 2001.
8. Budman CL, Park KS, Olson M, Bruun RD: Rage attacks in children and adolescents with Tourette syndrome: A pilot study. J Clin Psychiatry 59:576-580, 1998.
9. Budman CL, Bruun RD, Park KS, Lesser M, Olson M: Explosive outbursts in children with Tourette's disorder. J Am Acad Child Adolesc Psychiatry 39:1270-1276, 2000.
10. Budman CL, Rockmore L, Stokes J, Sossin M: Clinical phenomenology of episodic rage in children with Tourette syndrome. J Psychosom Res 55:59-65, 2003.
11. Casey DE, Carson WH, Saha AR, Liebeskind A, Ali MW, Jody D, Ingenito GG: Switching patients to aripiprazole from other antipsychotic agents: A multicenter randomized study. Psychopharmacology (Berl) 166:391-399, 2003.
12. Chen NC, Bedair HS, McKay B, Bowers MB, Mazure C: Clozapine in the treatment of aggression in an adolescent with autistic disorder (letter). J Clin Psychiatry 62:479-480, 2001.
13. Coffey BJ, Biederman J, Geller DA, Spencer T, Park KS, Shapiro SJ, Garfield SB: The course of Tourette's disorder: A literature review. Harv Rev Psychiatry 8:192-198, 2000a.
14. Coffey BJ, Biederman J, Geller DA, Spencer TJ, Kim GS, Bellordre CA, Frazier JA, Cradock K, Magovcevic: Distinguishing illness severity from tic severity in children and adolescents with Tourette's disorder. J Am Acad Child Adolesc Psychiatry 39:556-561, 2000b.
15. Coffey BJ, Biederman J, Spencer T, Geller DA, Faraone SV, Bellordre CA: Informativeness of structured diagnostic interviews in the identification of Tourette's disorder in referred youth. J Nerv Ment Dis 188:583-588, 2000c.
16. Coccaro EF, Kavoussi RJ, Berman ME, Lish JD. Intermittent explosive disorder-reviewed: Development, reliability, and validity of research criteria. Compr Psychiatry 1998 39:368-376, 1998
17. Cohen S, Rulf D, Pies R: Extrapyramidal side effects associated with aripiprazole coprescription in two patients. J Clin Psychiatry 66:135-136, 2005.
18. Comings DE, Comings BG: Hereditary agoraphobia and obsessive-compulsive behaviour in relatives of patients with Gilles de la Tourette's syndrome. Br J Psychiatry 151:195-199, 1987.
19. Dooley JM, Brna PM, Gordon KE: Parent perceptions of symptom severity in Tourette's syndrome. Arch Dis Child 81:440-441, 1999.
20. Findling R, McNamara N, Branicky L, Schulchter M, Lemon E, Blumer J: A double-blind pilot study of risperidone in the treatment of conduct disorder. J Am Acad Child Adolesc Psychiatry 39:509-516, 2000.
21. Findling RL, Blumer JL, Kauffman R, Batteson JR, Gilbert DL, Bramer S, Marcus R: Aripiprazole in pediatric conduct disorder: A pilot study. European Neuropsychopharmacol 13:S335, 2003. (Abstract)
22. Freeman RD, Rast DK, Burd L, Kerbeshian J, Robertson MM, Sandor P: An international perspective on Tourette syndrome: Selected findings from 3500 cases in 22 countries. Dev Med Child Neurology 42:436-447, 2000.
23. Green WH: Antipsychotic drugs, 3rd Ed. In: Child and Adolescent Clinical Psychopharmacology. Philadelphia, Lippincott, Williams and Wilkins, 2001, pp 89-114.
24. Halperin JM, McKay K, Newcorn, JH (2002), Development, reliability, and validity of the children's aggression scale-parent version. J Am Acad Child Adolesc Psychiatry 41:245-252.
25. Kadesjo B, Gillberg C: Tourette's disorder: Epidemiology and comorbidity in primary school children. J Am Acad Child Adolesc Psychiatry 39:548-555, 2000.
26. Kano Y, Masataka O, Nagai Y, Spector I, Budman C: Rage attacks and aggressive symptoms in Japanese adolescents with Tourette Syndrome. CNS Spectrums 13:325-332, 2008.
27. Kano Y, Ohta M, Nagai Y: Clinical characteristics of Tourette syndrome. Psych Clin Neurosci 52:51-57, 1998.
28. Kastrup A, Schlotter W, Plewnia C, Barthels M: Treatment of tics in Tourette syndrome with aripiprazole. J Clin Psychopharmacol 25:94-96, 2005.
29. Kurlan R, Como PG, Deeley C, McDermott M, McDermott MP: A pilot controlled study of fluoxetine for obsessive-compulsive symptoms in children with Tourette's syndrome. Clin Neuropharmacol 16:167-172, 1993.
30. Marder SR, McQuade RD, Stock E, Kaplita S, Marcus R, Safferman AZ, Saha A, Ali M, Iwamoto T: Aripiprazole in the treatment of schizophrenia: Safety and tolerability in short-term, placebo-controlled trials. Schizophr Res 61:123-136, 2003.
31. McDougle CJ, Holmes JP, Carlson DC, Pelton GH, Cohen DJ, Price LH: A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Arch Gen Psychiatry, 55:633-641, 1998.
32. McDougle CJ, Kem DL, Posey DJ: Case series: use of Ziprasidone for maladaptive symptoms in youths with autism. J Am Acad Child Adolesc Psychiatry 41:921-927, 2002.
33. Moldofsky H, Brown GM: Tics and serum prolactin response to pimozide in Tourette syndrome. Adv Neurol 35:387-390, 1982.
34. Murphy TK, Bengston MA, Soto O, Edge PJ, Sajid MW, Shapira N, Yang M: Case series on the use of aripiprazole for Tourette syndrome. Int J Neuropsychopharmacol Se 8:489-490, 2005.
35. Research Units on Pediatric Psychopharmacology Autism Network: Risperidone in children with autism and serious behavioral problems. N Engl J Med 347:314-321, 2002.
36. Riddle MA, Leckman JF, Hardin MT, Anderson GM, Cohen DJ: Fluoxetine treatment of obsessions and compulsions in patients with Tourette's syndrome. Am J Psychiatry 145:1173-1174, 1988.
37. Sandor P, Stephens R: Risperidone treatment of aggressive behavior in children with Tourette's Syndrome. J Clin Psychopharmacol 20:710-712, 2000.
38. Scahill L, Sukhodolsky DG, Bearss K, Findley D, Hamrin V, Carroll DH, Rains AL: Randomized trial of parent management training in children with tic disorders and disruptive behavior. J Child Neurol 21:650-656, 2006.
39. Scheier HA: Risperidone for young children with mood disorders and aggressive behavior. J Child Adolesc Psychopharmacol 8:49-59, 1998.
40. Shapiro AK, Shapiro E, Wayne H: Treatment of Tourette's syndrome with haloperidol, review of 34 cases. Arch Gen Psychiatry 28:92-97, 1973.
41. Singh MK, Delello M, Adler C. Acute dystonia associated with aripiprazole in a child. J Am Acad Child Adolesc Psychiatry 46(3); 306-307 2007.
42. Spalding S: Aripiprazole and atypical neuroleptic malignant syndrome. J Am Acad Child Adolesc Psychiatry 43:1457-1458, 2004.
43. Spencer T, Biederman J, Harding M, O'Donnell D, Wilens T, Faraone S, Coffey B, Geller D: Disentangling the overlap between Tourette's disorder and ADHD. J Child Psychol Psychiatry 39:1037-1044, 1998.
44. Stephens R, Sandor P: Aggressive behavior in children with Tourette syndrome and comorbid attention-deficit hyperactivity disorder and obsessive compulsive disorder. Can J Psychiatry 44:1036-1042, 1999.
45. Stephens RJ. Bassel C. Sandor P: Olanzapine in the treatment of aggression and tics in children with Tourette's syndrome-a pilot study. J Child Adolesc Psychopharmacol 14:255-266, 2004.
46. Stigler KP, Posey DJ, McDougle CJ: Aripiprazole for maladaptive behavior in pervasive developmental disorders. J Child Adolesc Psychopharmacol 14:455-463, 2004a.
47. Stigler K, Potenza M, Posey D, McDougle C: Weight gain associated with atypical antipsychotic use in children and adolescents: Prevalence, clinical relevance and management. Paediatric Drugs 6:33-44, 2004b
48. Stokes A, Bawden HN, Camfield PR, Backman JE, Dooley JM: Peer problems in Tourette's disorder. Pediatrics 87:936-942, 1991.
49. Storms L: Massed negative practice as a behavioral treatment for Gilles de la Tourette's syndrome. Am J Psychother 39:277-281, 1985.
50. Sukhodolsky DG, Scahill L, Zhang H, Peterson BS, King RA, Lombroso PJ, Katsovich L, Findley D, Leckman JF: Disruptive behavior in children with Tourette's syndrome: Association with ADHD comorbidity, tic severity, and functional impairment. J Am Acad Child Adolesc Psychiatry 42:98-105, 2003.
51. Thompson PDR. Physicians Desk Reference, 61st ed. Montvale (New Jersey): Thompson Healthcare, 2007.
52. Wand RR, Matazow GS, Shady GA, Furer P, Staley D: Tourette syndrome: Associated symptoms and most disabling features. Neurosci Biobehav Rev 17:271-275, 1993.
53. Yoo HK, Kim JY, Kim CY: A pilot study of aripiprazole in children and adolescents with Tourette's disorder. J Child and Adol Psychopharm 16: 505-506, 2006.